Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Disease Management Humans Mucormycosis / diagnosis

Journal

The Lancet. Infectious diseases
ISSN: 1474-4457
Titre abrégé: Lancet Infect Dis
Pays: United States
ID NLM: 101130150

Informations de publication

Date de publication:
12 2019
Historique:
received: 11 01 2019
revised: 10 04 2019
accepted: 05 06 2019
pubmed: 9 11 2019
medline: 17 6 2020
entrez: 9 11 2019
Statut: ppublish

Résumé

Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical intervention is lifesaving. Guidance on the complex multidisciplinary management has potential to improve prognosis, but approaches differ between health-care settings. From January, 2018, authors from 33 countries in all United Nations regions analysed the published evidence on mucormycosis management and provided consensus recommendations addressing differences between the regions of the world as part of the "One World One Guideline" initiative of the European Confederation of Medical Mycology (ECMM). Diagnostic management does not differ greatly between world regions. Upon suspicion of mucormycosis appropriate imaging is strongly recommended to document extent of disease and is followed by strongly recommended surgical intervention. First-line treatment with high-dose liposomal amphotericin B is strongly recommended, while intravenous isavuconazole and intravenous or delayed release tablet posaconazole are recommended with moderate strength. Both triazoles are strongly recommended salvage treatments. Amphotericin B deoxycholate is recommended against, because of substantial toxicity, but may be the only option in resource limited settings. Management of mucormycosis depends on recognising disease patterns and on early diagnosis. Limited availability of contemporary treatments burdens patients in low and middle income settings. Areas of uncertainty were identified and future research directions specified.

Identifiants

DOI: 10.1016/S1473-3099(19)30312-3 PMID: 31699664 PMC: PMC8559573
pubmed: 31699664
pii: S1473-3099(19)30312-3
doi: 10.1016/S1473-3099(19)30312-3
pmc: PMC8559573
mid: NIHMS1748809
pii:
doi:

Types de publication

Journal Article Practice Guideline Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e405-e421

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI063503
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Mil Med. 2018 Sep 1;183(suppl_2):142-146
pubmed: 30189071
J Med Microbiol. 2016 Dec;65(12):1414-1421
pubmed: 27902424
J Clin Microbiol. 2014 May;52(5):1737-40
pubmed: 24574295
Haematologica. 2004 Feb;89(2):207-14
pubmed: 15003897
Am J Kidney Dis. 1993 Sep;22(3):393-7
pubmed: 8372834
Infect Chemother. 2013 Sep;45(3):292-8
pubmed: 24396630
J Antimicrob Chemother. 2015 Nov;70(11):3116-23
pubmed: 26316385
J Clin Microbiol. 2008 Jul;46(7):2353-8
pubmed: 18480229
Mycoses. 2018 Dec;61(12):909-915
pubmed: 30091261
Mycoses. 2018 Jul;61(7):485-497
pubmed: 29611227
Indian J Med Microbiol. 2008 Jul-Sep;26(3):269-71
pubmed: 18695332
Clin Microbiol Infect. 2011 Dec;17(12):1859-67
pubmed: 21199154
Clin Infect Dis. 2012 Dec;55(11):1441-9
pubmed: 23042971
Neurointervention. 2012 Feb;7(1):45-9
pubmed: 22454785
Mycopathologia. 2017 Dec;182(11-12):1111-1117
pubmed: 28667347
Leuk Lymphoma. 2004 Jul;45(7):1351-60
pubmed: 15359632
Clin Microbiol Infect. 2015 Jun;21(6):594.e1-5
pubmed: 25726039
Mycol Res. 2007 May;111(Pt 5):509-47
pubmed: 17572334
Clin Infect Dis. 2007 Apr 15;44(8):1078-83
pubmed: 17366453
Clin Infect Dis. 2009 Aug 1;49(3):e39-43
pubmed: 19566442
Jpn J Infect Dis. 2013;66(4):345-7
pubmed: 23883851
J Clin Microbiol. 2008 Nov;46(11):3690-702
pubmed: 18845827
Mycoses. 2014 Dec;57 Suppl 3:91-6
pubmed: 25187314
N Engl J Med. 2012 Dec 6;367(23):2214-25
pubmed: 23215557
J Antimicrob Chemother. 2016 Jun;71(6):1747
pubmed: 26960721
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28607011
Blood. 2011 Aug 4;118(5):1216-24
pubmed: 21622653
Transpl Infect Dis. 2007 Jun;9(2):161-4
pubmed: 17462005
Postgrad Med J. 2004 Nov;80(949):670-4
pubmed: 15537854
Am J Transplant. 2009 Sep;9(9):2166-71
pubmed: 19681829
Med Mycol. 2019 Jun 1;57(4):395-402
pubmed: 30085158
J Antimicrob Chemother. 2010 Feb;65(2):296-302
pubmed: 20008047
Clin Infect Dis. 2012 Feb;54 Suppl 1:S44-54
pubmed: 22247444
J Clin Microbiol. 2010 Jun;48(6):2043-6
pubmed: 20375233
Med Mycol. 2010 May;48(3):511-7
pubmed: 19824881
J Otolaryngol. 2005 Dec;34(6):402-6
pubmed: 16343400
Antimicrob Agents Chemother. 2014 Jul;58(7):3610-7
pubmed: 24733463
J Urol. 2004 Jan;171(1):387-8
pubmed: 14665938
Med Mycol. 2017 Jun 1;55(4):385-395
pubmed: 27630252
J Dermatol Sci. 2005 Jul;39(1):23-31
pubmed: 15978416
Med Sci (Paris). 2013 Mar;29 Spec No 1:7-12
pubmed: 23510519
Clin Microbiol Infect. 2014 Apr;20 Suppl 3:5-26
pubmed: 24479848
Exp Clin Transplant. 2014 Mar;12 Suppl 1:72-5
pubmed: 24635797
Lancet Infect Dis. 2016 Jul;16(7):761-762
pubmed: 26969257
Br J Surg. 1991 Aug;78(8):952-4
pubmed: 1913115
Indian J Crit Care Med. 2018 May;22(5):375-377
pubmed: 29910552
Oral Dis. 2006 Jan;12(1):67-9
pubmed: 16390472
Eur J Clin Microbiol Infect Dis. 2001 Jul;20(7):460-6
pubmed: 11561801
Medicine (Baltimore). 2016 Jul;95(27):e4185
pubmed: 27399143
Arch Pathol Lab Med. 2001 Mar;125(3):375-8
pubmed: 11231486
Ophthalmic Plast Reconstr Surg. 2017 Jul/Aug;33(4):e94-e97
pubmed: 27768642
Haematologica. 2017 Mar;102(3):433-444
pubmed: 28011902
Antimicrob Agents Chemother. 2003 Nov;47(11):3647-50
pubmed: 14576138
Haematologica. 2013 Apr;98(4):492-504
pubmed: 22983580
Crit Rev Microbiol. 2013 Aug;39(3):310-24
pubmed: 22917084
Am J Perinatol. 2009 Sep;26(8):565-73
pubmed: 19391079
J Clin Microbiol. 2010 Sep;48(9):3392-4
pubmed: 20592150
Lancet. 2015 Jun 6;385(9984):2322
pubmed: 26088500
Clin Infect Dis. 2008 Aug 15;47(4):503-9
pubmed: 18611163
J Clin Microbiol. 2016 Nov;54(11):2798-2803
pubmed: 27605714
Mycoses. 2014 Dec;57 Suppl 3:2-7
pubmed: 25475924
Br J Radiol. 2006 Jul;79(943):e19-21
pubmed: 16823048
J Infect. 2009 Aug;59(2):134-8
pubmed: 19576639
J Med Microbiol. 2017 Aug;66(8):1124-1129
pubmed: 28792370
Mycoses. 2014 Nov;57(11):687-98
pubmed: 25040241
Med Intensiva. 2017 Nov;41(8):509-510
pubmed: 27207730
J Clin Microbiol. 2009 Sep;47(9):2834-43
pubmed: 19641069
Br J Haematol. 1997 Nov;99(2):331-6
pubmed: 9375750
mBio. 2018 Apr 24;9(2):
pubmed: 29691339
Clin Infect Dis. 2008 Aug 1;47(3):364-71
pubmed: 18558882
Ann Thorac Surg. 1994 Apr;57(4):1044-50
pubmed: 8166512
Pathol Res Pract. 2016 May;212(5):393-7
pubmed: 26874574
Surg Neurol Int. 2016 May 25;7:61
pubmed: 27280057
J Pathol. 1997 Jan;181(1):100-5
pubmed: 9072010
Clin Infect Dis. 1998 Jun;26(6):1383-96
pubmed: 9636868
Med Mycol. 2018 Jan 1;56(1):29-43
pubmed: 28431008
Antimicrob Agents Chemother. 2001 Dec;45(12):3487-96
pubmed: 11709329
Clin Infect Dis. 2012 Feb;54 Suppl 1:S35-43
pubmed: 22247443
PLoS One. 2012;7(11):e49989
pubmed: 23209631
Postgrad Med J. 2009 Nov;85(1009):573-81
pubmed: 19892892
Mycoses. 2018 Nov;61(11):885-894
pubmed: 30086186
Clin Microbiol Rev. 2011 Apr;24(2):411-45
pubmed: 21482731
J Oral Maxillofac Surg. 2018 Sep;76(9):1930.e1-1930.e5
pubmed: 29458027
Clin Otolaryngol. 2018 Dec;43(6):1454-1464
pubmed: 29947167
PLoS One. 2017 Jun 7;12(6):e0179136
pubmed: 28591186
Int J Antimicrob Agents. 2018 Nov;52(5):706-712
pubmed: 30099056
J Infect Dis. 2009 Sep 15;200(6):1002-11
pubmed: 19659439
Clin Microbiol Infect. 2016 Sep;22(9):811.e1-811.e8
pubmed: 27085727
J Chemother. 2009 Jun;21(3):322-9
pubmed: 19567354
Mycoses. 2019 Jan;62(1):81-86
pubmed: 30230043
N Engl J Med. 1999 Mar 11;340(10):764-71
pubmed: 10072411
Clin Infect Dis. 2016 Nov 15;63(10):1312-1317
pubmed: 27535951
Clin Infect Dis. 2007 Oct 1;45(7):e101-4
pubmed: 17806041
Clin Microbiol Rev. 2011 Apr;24(2):247-80
pubmed: 21482725
Mycoses. 2019 Mar;62(3):252-260
pubmed: 30565742
J Microbiol Immunol Infect. 2018 Feb;51(1):1-17
pubmed: 28781150
Haematologica. 2000 Oct;85(10):1068-71
pubmed: 11025599
Lancet. 2005 Mar 5-11;365(9462):830-1
pubmed: 15752513
Int J Med Microbiol. 2002 Oct;292(5-6):373-80
pubmed: 12452283
Antimicrob Agents Chemother. 2008 Apr;52(4):1556-8
pubmed: 18212099
J Clin Microbiol. 2011 Jun;49(6):2151-3
pubmed: 21508149
Mycoses. 2016 Nov;59(11):726-733
pubmed: 27392814
Clin Infect Dis. 2008 Jun 1;46(11):1733-7
pubmed: 18419427
Antimicrob Agents Chemother. 2008 Apr;52(4):1573-6
pubmed: 18227182
J Laryngol Otol. 2017 Sep;131(9):813-816
pubmed: 28841131
Antimicrob Agents Chemother. 2009 Feb;53(2):772-5
pubmed: 18936190
Medicine (Baltimore). 2018 Jun;97(25):e11141
pubmed: 29924015
Clin Infect Dis. 2007 May 15;44(10):1289-97
pubmed: 17443465
AJR Am J Roentgenol. 2018 Apr;210(4):742-747
pubmed: 29470162
Med Mycol. 2008 Aug;46(5):491-4
pubmed: 18608916
J Med Microbiol. 2016 Mar;65(3):227-234
pubmed: 26743820
Clin Infect Dis. 2005 Sep 1;41(5):634-53
pubmed: 16080086
Intern Med J. 2014 Dec;44(12b):1333-49
pubmed: 25482744
J Antimicrob Chemother. 2017 Dec 1;72(12):3406-3413
pubmed: 28961714
Clin Infect Dis. 2015 Dec 1;61(11):1664-70
pubmed: 26240202
Eur Radiol. 2018 Feb;28(2):788-795
pubmed: 28812135
Clin Microbiol Infect. 2013 Jun;19(6):E271-7
pubmed: 23464751
Clin Microbiol Infect. 2012 Oct;18(10):E396-400
pubmed: 22672535
Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):157-165
pubmed: 29027030
Clin Infect Dis. 2012 Feb;54 Suppl 1:S8-S15
pubmed: 22247451
J Clin Microbiol. 2007 Feb;45(2):380-5
pubmed: 17122000
Clin Microbiol Infect. 2009 Oct;15 Suppl 5:37-40
pubmed: 19754755
Clin Infect Dis. 2014 Mar;58(5):672-8
pubmed: 24352351
Mycopathologia. 2014 Dec;178(5-6):465-70
pubmed: 25086667
Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):8-13
pubmed: 16416267
Mycoses. 2018 Apr;61(4):256-260
pubmed: 29178247
Clin Infect Dis. 2006 Apr 1;42(7):e61-5
pubmed: 16511748
Clin Infect Dis. 2006 Aug 15;43(4):e29-38
pubmed: 16838223
Clin Microbiol Infect. 2013 Jan;19(1):E1-E7
pubmed: 22925434
Antimicrob Agents Chemother. 2006 Jan;50(1):126-33
pubmed: 16377677
Int J Clin Exp Pathol. 2015 Nov 01;8(11):14840-52
pubmed: 26823814
Diagn Mol Pathol. 2002 Jun;11(2):119-26
pubmed: 12045716
Antimicrob Agents Chemother. 2014 Oct;58(10):5758-65
pubmed: 25049247
Mycoses. 2010 Jan;53(1):89-92
pubmed: 19207832
J Clin Microbiol. 2006 Feb;44(2):340-9
pubmed: 16455881
Mycopathologia. 2016 Oct;181(9-10):723-33
pubmed: 27350324
Med Mycol. 2013 Jan;51(1):72-82
pubmed: 22686246
Med Mycol. 2010 Dec;48(8):1088-95
pubmed: 20367111
J Glob Infect Dis. 2015 Oct-Dec;7(4):143-50
pubmed: 26752868
J Clin Pathol. 2005 Nov;58(11):1180-4
pubmed: 16254108
Lancet Infect Dis. 2011 Apr;11(4):301-11
pubmed: 21453871
Med Mycol. 2006 Aug;44(5):461-6
pubmed: 16882613
Lancet. 2016 Feb 20;387(10020):760-9
pubmed: 26684607
Mycoses. 2017 Jul;60(7):420-425
pubmed: 28497502
Lancet Infect Dis. 2016 Jul;16(7):828-837
pubmed: 26969258

Auteurs

Oliver A Cornely (OA)

Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF) partner site Bonn-Cologne, Cologne, Germany; CECAD Cluster of Excellence, University of Cologne, Cologne, Germany; Clinical Trials Center Cologne, University Hospital of Cologne, Cologne, Germany. Electronic address: oliver.cornely@uk-koeln.de.

Ana Alastruey-Izquierdo (A)

Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.

Dorothee Arenz (D)

Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; CECAD Cluster of Excellence, University of Cologne, Cologne, Germany.

Sharon C A Chen (SCA)

Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, and the Department of Infectious Diseases, Westmead Hospital, School of Medicine, University of Sydney, Sydney, NSW, Australia.

Eric Dannaoui (E)

Université Paris-Descartes, Faculté de Médecine, APHP, Hôpital Européen Georges Pompidou, Unité de Parasitologie-Mycologie, Service de Microbiologie, Paris, France.

Bruno Hochhegger (B)

Radiology, Hospital São Lucas da Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS), Escola de Medicina, Porto Alegre, Brazil; Radiology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil.

Martin Hoenigl (M)

Section of Infectious Diseases and Tropical Medicine and Division of Pulmonology, Medical University of Graz, Graz, Austria; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, USA.

Henrik E Jensen (HE)

Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Katrien Lagrou (K)

Department of Microbiology, Immunology and Transplantation, KU Leuven and Clinical Department of Laboratory Medicine and National Reference Center for Mycosis, University Hospitals Leuven, Leuven, Belgium.

Russell E Lewis (RE)

Infectious Diseases Clinic, Sant'Orsola-Malpighi Hospital, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Sibylle C Mellinghoff (SC)

Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; CECAD Cluster of Excellence, University of Cologne, Cologne, Germany.

Mervyn Mer (M)

Divisions of Critical Care and Pulmonology, Department of Medicine, Charlotte Maxeke Johannesburg Academic Hospital and Faculty of Health Sciences University of the Witwatersrand, Johannesburg, South Africa.

Zoi D Pana (ZD)

Infectious Diseases Unit, 3rd Department of Paediatrics, Faculty of Medicine, Aristotle University School of Health Sciences, Thessaloniki, Greece; Hippokration General Hospital, Thessaloniki, Greece.

Danila Seidel (D)

Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; CECAD Cluster of Excellence, University of Cologne, Cologne, Germany.

Donald C Sheppard (DC)

Division of Infectious Diseases, Department of Medicine, Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.

Roger Wahba (R)

Department of General, Visceral and Cancer Surgery, University Hospital of Cologne, Cologne, Germany.

Murat Akova (M)

Department of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey.

Alexandre Alanio (A)

Institut Pasteur, National Reference Center for Invasive Mycoses and Antifungals, Department of Mycology, CNRS UMR2000, Parasitology-Mycology Laboratory, Lariboisière, Saint-Louis, Fernand Widal Hospitals, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.

Abdullah M S Al-Hatmi (AMS)

Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands; Centre of Expertise in Mycology RadboudUMC/Canisius Wilhelmina Hospital, Nijmegen, The Netherlands; Ministry of Health, Directorate General of Health Services, Ibri, Oman.

Sevtap Arikan-Akdagli (S)

Department of Medical Microbiology, Hacettepe University School of Medicine, Sıhhiye Ankara, Turkey.

Hamid Badali (H)

Department of Medical Mycology/Invasive Fungi Research Center (IFRC), School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Ronen Ben-Ami (R)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Infectious Diseases Unit, Tel Aviv Medical Center, Tel- Aviv, Israel.

Alexandro Bonifaz (A)

Dermatology Service & Mycology Department, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico.

Stéphane Bretagne (S)

Institut Pasteur, National Reference Center for Invasive Mycoses and Antifungals, Department of Mycology, CNRS UMR2000, Parasitology-Mycology Laboratory, Lariboisière, Saint-Louis, Fernand Widal Hospitals, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.

Elio Castagnola (E)

Infectious Diseases Unit, Istituto Giannina Gaslini Children's Hospital, Genoa, Italy.

Methee Chayakulkeeree (M)

Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Arnaldo L Colombo (AL)

Special Mycology Laboratory, Division of Infectious Diseases, Department of Medicine, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.

Dora E Corzo-León (DE)

Department of Epidemiology and Infectious Diseases, Hospital General Dr Manuel Gea González, Mexico City, Mexico; Medical Mycology and Fungal Immunology/Wellcome Trust Strategic Award Program, Aberdeen Fungal Group, University of Aberdeen, King's College, Aberdeen, UK.

Lubos Drgona (L)

Oncohematology Clinic, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.

Andreas H Groll (AH)

InfectiousDisease Research Program, Department of Paediatric Hematology/Oncology and Center for Bone Marrow Transplantation, University Children's Hospital Münster, Münster, Germany.

Jesus Guinea (J)

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación v Sanitaria Gregorio Marañón, Madrid, Spain; Medicine Department, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Claus-Peter Heussel (CP)

Diagnostic and Interventional Radiology, Thoracic Clinic, University Hospital Heidelberg, Heidelberg, Germany.

Ashraf S Ibrahim (AS)

Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles (UCLA) Medical Center, Torrance, CA, USA.

Souha S Kanj (SS)

Department of Internal Medicine, Division of Infectious Diseases, American University of Beirut Medical Center, Beirut, Lebanon.

Nikolay Klimko (N)

Department of Clinical Mycology, Allergology and Immunology, North Western State Medical University, St Petersburg, Russia.

Michaela Lackner (M)

Division of Hygiene and Medical Microbiology, Department of Hygiene, Microbiology and Public Health, Medical University Innsbruck, Innsbruck, Austria.

Frederic Lamoth (F)

Infectious Diseases Service, Department of Medicine and Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland; Institute of Microbiology, Department of Laboratories, Lausanne University Hospital, Lausanne, Switzerland.

Fanny Lanternier (F)

Institut Pasteur, National Reference Center for Invasive Mycoses and Antifungals, Department of Mycology, Paris Descartes University, Necker-Enfants Malades University Hospital, Department of Infectious Diseases and Tropical Medicine, Centre d'Infectiologie Necker-Pasteur, Institut Imagine, AP-HP, Paris, France.

Cornelia Lass-Floerl (C)

Division of Hygiene and Medical Microbiology, Department of Hygiene, Microbiology and Public Health, Medical University Innsbruck, Innsbruck, Austria.

Dong-Gun Lee (DG)

Division of Infectious Diseases, Department of Internal Medicine, Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul, Korea.

Thomas Lehrnbecher (T)

Division of Paediatric Haematology and Oncology, Hospital for Children and Adolescents, Johann Wolfgang Goethe-University, Frankfurt, Germany.

Badre E Lmimouni (BE)

School of Medicine and Pharmacy, University Mohammed the fifth, Hay Riad, Rabat, Morocco.

Mihai Mares (M)

Laboratory of Antimicrobial Chemotherapy, Ion Ionescu de la Brad University, Iaşi, Romania.

Georg Maschmeyer (G)

Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Germany.

Jacques F Meis (JF)

Department of Medical Microbiology and Infectious Diseases, Centre of Expertise in Mycology Radboudumc/Canisius Wilhelmina Hospital, Nijmegen, Netherlands.

Joseph Meletiadis (J)

Clinical Microbiology Laboratory, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.

C Orla Morrissey (CO)

Department of Infectious Diseases, Alfred Health & Monash University, Melbourne, Australia.

Marcio Nucci (M)

Department of Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Rita Oladele (R)

Department of Medical Microbiology & Parasitology, College of Medicine, University of Lagos, Yaba, Lagos, Nigeria; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Livio Pagano (L)

Department of Hematology, Fondazione Policlinico Universitario A. Gemelli -IRCCS- Universita Cattolica del Sacro Cuore, Roma, Italy.

Alessandro Pasqualotto (A)

Federal University of Health Sciences of Porto Alegre, Hospital Dom Vicente Scherer, Porto Alegre, Brazil.

Atul Patel (A)

Infectious Diseases Clinic, Vedanta Institute of Medical Sciences, Navarangpura, Ahmeddabad, India.

Zdenek Racil (Z)

Institute of Hematology and Blood Transfusion, Prague, Czech Republic.

Malcolm Richardson (M)

UK NHS Mycology Reference Centre, Manchester University NHS Foundation Trust, Manchester, UK.

Emmanuel Roilides (E)

Infectious Diseases Unit, 3rd Department of Paediatrics, Faculty of Medicine, Aristotle University School of Health Sciences, Thessaloniki, Greece; Hippokration General Hospital, Thessaloniki, Greece.

Markus Ruhnke (M)

Hämatologie & Internistische Onkologie, Lukas-Krankenhaus Bünde, Onkologische Ambulanz, Bünde, Germany.

Seyedmojtaba Seyedmousavi (S)

Department of Medical Mycology/Invasive Fungi Research Center (IFRC), School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Center of Expertise in Microbiology, Infection Biology and Antimicrobial Pharmacology, Tehran, Iran; Molecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Neeraj Sidharthan (N)

Department of Hemato Oncology, Amrita Institute of Medical Sciences, Amrita Viswa Vidyapeetham University, Kochi, India.

Nina Singh (N)

Division of Infectious Diseases, University of Pittsburgh Medical Center and VA Pittsburgh Healthcare System, Infectious Diseases Section, University of Pittsburgh, Pittsburgh, PA, USA.

János Sinko (J)

Infectious Diseases Unit, Szent Istvan and Szent Laszlo Hospital, Budapest, Hungary.

Anna Skiada (A)

Department of Infectious Diseases, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Monica Slavin (M)

University of Melbourne, Melbourne, VIC, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Melbourne, VIC, Australia.

Rajeev Soman (R)

P D Hinduja Hospital & Medical Research Centre, Department of Medicine, Veer Sarvarkar Marg, Mumbai, India.

Brad Spellberg (B)

Los Angeles County and University of Southern California (LAC+USC) Medical Center, Los Angeles, CA, USA.

William Steinbach (W)

Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.

Ban Hock Tan (BH)

Department of Infectious Diseases, Singapore General Hospital, Singapur, Singapore.

Andrew J Ullmann (AJ)

Department for Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.

Jörg J Vehreschild (JJ)

Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF) partner site Bonn-Cologne, Cologne, Germany; Department of Internal Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany.

Maria J G T Vehreschild (MJGT)

Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF) partner site Bonn-Cologne, Cologne, Germany; Department of Internal Medicine, Infectious Diseases, Goethe University Frankfurt, Frankfurt, Germany.

Thomas J Walsh (TJ)

Departments of Medicine, Pediatrics, Microbiology & Immunology, Weill Cornell Medicine, and New York Presbyterian Hospital, New York City, NY, USA.

P Lewis White (PL)

Public Health Wales Microbiology Cardiff, UHW, Heath Park, Cardiff, UK.

Nathan P Wiederhold (NP)

Fungus Testing Laboratory, University of Texas Health Science Center, San Antonio, TX, USA.

Theoklis Zaoutis (T)

Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Arunaloke Chakrabarti (A)

Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Prise en charge de la maladie › Global guideline for the diagnosis and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Global guideline for the diagnosis and...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Mycoses › Zygomycose › Mucormycose › Global guideline for the diagnosis and...